Investor Presentaiton

Management & Board of Directors Team with Success in Drug Discovery and Development Bryan Kobel - Chief Executive Officer ■ More than 15 years of capital markets / banking experience in Healthcare and Life Sciences Former Head of Healthcare Investment Banking at EF Hutton ■ Previous Head of Healthcare for the Alberleen Group Martin Thorp - Chief Financial Officer TC BIOPHARM ■ Founder & Global CEO of Arthur Andersen Corporate Finance (NYC HQ) 30 years experience in implementing capital strategies (seed to IPO) Founder NCL: life science investor and regulated adviser to life science enterprises Dr. Mark Bonyhadi James Culverwell Arlene Morris (Chairperson) Edward Niemczyk ■ ◉ Senior Advisor at Qiming Venture Partners USA Various positions held from 2013-2018 at Juno Therapeutics Former Director of Global Business Development for Cell Therapy at Invitrogen, which was merged with Applied BioSystems, to create Life Technologies, which subsequently was acquired by Thermo-Fisher Former Director and later Vice President of Research at Xycte Therapies, a T cell therapy company treating cancer, infectious disease, and autoimmunity Served as a non-executive director and chairman of the audit committee of Innocoll Holdings plc (a collagen-based drug delivery company) from 2013 until 2017 ■ Non-executive director and chairman of the audit committee of Safeguard Biosystems, a private company providing high throughput, multiplexed, molecular diagnostic tests and now generating commercial revenues ■ Former director and chairman of the audit committee of Amryt Pharmaceuticals plc, a commercial and research-based company specializing in rare diseases Non-executive director of the following companies: Cogent Biosciences, Inc. (NASDAQ: COGT), Viridian Therapeutics, Inc. (NASDAQ: VRDN), and Palatin Technologies, Inc. (NYSE: PTN) Former non-executive director at the following companies: Neovacs SA (2011 to 2021), Dimension Therapeutics, Inc. (2015-018), Biodel, Inc. (2012-2015), Medici Nova, Inc. (2006-2013) Emeritus member of the board of directors at the Medical University of South Carolina ('MUSC') (since 2012) and is also (since 2016) a member of the board of trustees of Carlow University (PA) Lead healthcare partner with the private equity firm, Bridges Fund Management, Ltd since 2016 Served on the board of directors of the following private companies which are investees of Bridges: Impact Fitness North America, LP (2016 to 2019); Medwood Holdings, LLC (2018-); Sunrise Treatment Holdings, LLC (chairman of the board) (2019 -); Jump City Holdings, Inc (chairman of the board) (2019 -); JRHH Holdings, LLC (2020 -) Former vice president of The Beekman Group, LLC between 2013 and 2016 and prior to that with the private equity firm Cordova, Smart and Williams, LLC (2006-2013) and GE Capital Corporation (2002-2006) 16

View entire presentation